HENGRUI PHARMA (01276) has announced that its 2025 profit distribution plan has been approved by shareholders. The board declared a cash dividend of RMB 2 per 10 shares (tax inclusive) as the final dividend for 2025. The dividend will be paid to H-shareholders registered in the company's H-share register on Monday, May 11, 2026 (the record date). The final dividend for 2025 is scheduled to be distributed to H-shareholders on Wednesday, May 27, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments